Analytical control of genotoxic impurities in the pazopanib hydrochloride manufacturing process-Reference-Cited by-同舟云学术

Analytical control of genotoxic impurities in the pazopanib hydrochloride manufacturing process

Published:2009-09 Issue:2 Volume:50 Page:144-150
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Liu David Q.,Chen Ted K.,McGuire Michael A.,Kord Alireza S.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference15 articles.

1. Committee for medicinal products for human use (CHMP), European Medicines Agency (EMEA), London, 28 June 2006 (CPMP/SWP/5199/02, EMEA/CHMP/QWP/251344/2006).

2. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity

3. US Food and Drug Administration CDER Guidance for industry, http://www.fda.gov/cder/guidance/7834dft.pdf (accessed 14 January 2009).

4. An impact analysis of the application of the threshold of toxicological concern concept to pharmaceuticals

5. Regulation of genotoxic and carcinogenic impurities in drug substances and products

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation and Characterization of Pazopanib Hydrochloride-Loaded Four-Component Self-Nanoemulsifying Drug Delivery Systems Preconcentrate for Enhanced Solubility and Dissolution;Pharmaceutics;2022-09-05

2. High-performance thin-layer chromatography-based method development for the analysis of 4-methoxy-2-nitroaniline as potential genotoxic impurity;JPC – Journal of Planar Chromatography – Modern TLC;2022-02

3. Computers in Pharmaceutical Analysis;Computer Aided Pharmaceutics and Drug Delivery;2022

4. Development and Validation of HPLC Determination of related Substances in A Novel Anticonvulsant agent Epimidin;Research Journal of Pharmacy and Technology;2021-06-29

5. Critical Analysis of Drug Product Recalls due to Nitrosamine Impurities;Journal of Medicinal Chemistry;2021-03-11